Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ansornitinib is an oral, active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).Ansornitinib is an antifibrotic agent that can be used to study fibrotic diseases of the lung, liver, kidney, and gastrointestinal tract.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,310.00 | |
50 mg | 6-8 weeks | $ 1,710.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Ansornitinib is an oral, active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).Ansornitinib is an antifibrotic agent that can be used to study fibrotic diseases of the lung, liver, kidney, and gastrointestinal tract. |
Molecular Weight | 540.61 |
Formula | C30H32N6O4 |
CAS No. | 1448874-96-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ansornitinib 1448874-96-1 inhibitor inhibit